IP Library Granted Patent US 8,207,346
Granted Patent B2
US 8,207,346 · App. 12/729,346 · Granted Jun 26, 2012

Methods of synthesizing anatabine

Assignee: Rock Creek Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,207,346
App. No.
12/729,346
Granted
Jun 26, 2012
Kind
B2
Abstract

Anatabine is obtained by reacting benzophenoneimine with 3-aminomethyl pyridine to form benzylhydrylidene-pyridin-3-yl-methyl-amine. The benzylhydrylidene-pyridin-3-yl-methyl-amine is treated with a non-nucleophilic base and a dielectrophile, such as cis-1,4-dichloro-2-butene, followed by acidification, then basification, to provide anatabine. The resulting anatabine is substantially free from contaminants and displays good stability. In an alternative embodiment, the benzylhydrylidene-pyridin-3-yl-methyl-amine may be used in the synthesis of other alkaloids such as anabasine, nornicotine, N-methylanabasine, and anabaseine.

Claims (8)

1. A method of synthesizing anatabine comprising the steps of:

(a) reacting 3-aminomethyl pyridine with benzophenoneimine to obtain a compound of Formula I:

(b) reacting the compound of Formula I with a non-nucleophilic base and a dielectrophile to obtain a compound of Formula II:

wherein X is a halogen,

(c) treating the compound of Formula II with an acid to obtain a compound of Formula III:

wherein X is a halogen; and

(d) treating the compound of Formula III with at least one base to obtain anatabine.

2. The method of claim 1 , further comprising extracting the reaction product obtained in step (d) with methyl tert-butyl ether (MTBE) solvent and removing the solvent by distillation to recover purified anatabine.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2018
From: ROCK CREEK PHARMACEUTICALS, INC.
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 046780/0050 →
CHANGE OF NAME Recorded Jul 14, 2014
From: ROCK CREEK PHARMACEUTICALS, INC.
To: RCP DEVELOPMENT, INC.
Reel/Frame 033309/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2010
From: PUTHIAPARAMPIL, TOM THOMAS; DAVID, THOMAS KANATHKUNN; RAJU, MUPPALA SARVESWARA
To: ROCK CREEK PHARMACEUTICALS, INC.
Reel/Frame 024123/0868 →
Continuity (1)
Related Publication 20110237627A1 · Sep 29, 2011